Baxano Surgical
BAXS
BAXS was delisted on the 21st of November, 2014.
3 hedge funds and large institutions have $0 invested in Baxano Surgical in 2015 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
50% less funds holding
Funds holding: 6 → 3 (-3)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $2K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Texas Yale Capital
St. Petersburg,
Florida
|
-$2K |
BAXS Hedge Fund Activity: Q1 2015 in Review
3 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Baxano Surgical (BAXS) for Q1 2015, worth a combined $0 — down 100% from $2K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BAXS and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Texas Yale Capital, exiting entirely with an estimated $2K sold.
- 3 institutional investors held Baxano Surgical (BAXS) as of Q1 2015, down from 6 in Q4 2014.
- Funds reported $0 of Baxano Surgical stock for Q1 2015, down 100% quarter-over-quarter.
- 0 funds opened new Baxano Surgical positions in Q1 2015 and 3 closed out, a net change of -3 holders.
- The largest Baxano Surgical seller in Q1 2015 was Texas Yale Capital, an estimated $2K sold.
Based on aggregated 13F filings for Q1 2015.